Searchicon: search

Introducing
Nobivac EdgeĀ®
Vaccines

Full Size Protection, Half Size Vaccines

Choose the best protection for your clients with convenient small dose options that deliver powerful protection for dogs of all sizes.

NOBIVAC EDGEĀ® LEPTO4

NOBIVAC EDGEĀ® DAPPv

NOBIVAC EDGEĀ® DAPPv+L4

The first and only 0.5 mL leptospirosis vaccine shown to be effective
against disease, mortality and shedding for dogs of all sizes.

NOBIVAC EDGEĀ® LEPTO4

DELIVERS 4-WAYLEPTOSPIROSIS PROTECTION

  • Shown to be effective against disease, mortality, and leptospiruria caused by four Leptospira serovars:2,5
    • L. canicola
    • L. icterohaemorrhagiae
    • L. pomona
    • L. grippotyphosa

VACCIPUREā„¢ FILTRATION TECHNOLOGY

  • A porous filtration membrane selectively removes extraneous proteins, salts, and solvents
  • Fewer total proteins (TP) means a more purified final product, which may reduce unwanted immune system responses such as vaccine reactions1
  • Promotes a higher level of vaccine quality
  • Same process used for NobivacĀ® Lepto4, NobivacĀ® Canine-1 DAPPv+L4, and Nobivac EDGEĀ® Lepto4

The only 0.5 mL that provides protection
against parainfluenza, distemper, adenovirus type 1 (hepatitis),
and parvovirus in one formula.

NOBIVAC EDGEĀ® DAPPv

PROVEN PROTECTION

  • The only 0.5 mL combination vaccine formula to include parainfluenza
  • Protects against all known strains of canine parvovirus (CPV), including CPV-2c3,4
  • Contains CPV-2b, one of the most prevalent field strains of parvovirus
  • High antigenic mass (titer), low passage parvovirus vaccine
  • Overrides CPV maternal antibodies in young puppies1
  • Protects against adenovirus type 1 that causes hepatitis in dogs
  • Systemic administration stimulates a strong IgG response (CPiV)1

NOBIVACĀ® SAFETY & QUALITY

  • Lower total protein level than other 0.5 ml vaccine options1
  • Onderstepoort-type strain in NobivacĀ® vaccines provides a high level of safety (CDV)1

The only 0.5 mL combo vaccine to provide parainfluenza protection
in combination with four-way leptospirosis protection.

NOBIVAC EDGEĀ® DAPPv+L4

CONVENIENT COMBO PROTECTION

  • The only 0.5 mL leptospirosis vaccine to aid in the prevention of disease, mortality, and leptospiriuria caused by four Leptospira serovars2,5
  • The only 0.5 mL combination vaccine formula to include parainfluenza
  • Protects against all known strains of canine parvovirus (CPV), including CPV-2c3,4
  • Contains CPV-2b, one of the most prevalent field strains of parvovirus
  • High antigenic mass (titer), low passage parvovirus vaccine
  • Overrides CPV maternal antibodies in young puppies1
  • Systemic administration stimulates a strong IgG response (CPiV)1
  • Protects against adenovirus type 1 that causes hepatitis in dogs

NOBIVACĀ® SAFETY & QUALITY

  • 99% Reaction Free: out of 1,583 doses given in Clinical Impressions study1
  • Lower total protein level than other 0.5 ml vaccine options1
  • Onderstepoort-type strain in NobivacĀ® vaccines provides a high level of safety (CDV)1

LEPTO4 VACCIPUREā„¢ FILTRATION TECHNOLOGY

  • A porous filtration membrane selectively removes extraneous proteins, salts, and solvents
  • Fewer total proteins (TP) means a more purified final product, which may reduce unwanted immune system responses such as vaccine reactions1
  • Promotes a higher level of vaccine quality
  • Same process used for NobivacĀ® Lepto4, NobivacĀ® Canine-1 DAPPv+L4, and Nobivac EDGEĀ® Lepto4

GET NOBIVAC EDGEĀ® FULL SIZE PROTECTION, HALF SIZE VACCINES

Get the proven efficacy of Nobivac EDGEĀ® 0.5 mL for dogs of all sizes.

CONTACT US

TECHNICAL ASSISTANCE

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318

References

  1. View All Nobivac References